Cargando…

Safety and efficacy of flow diverter stents in the treatment of middle cerebral artery aneurysms: a single-center experience and follow-up data

PURPOSE: This study aims to evaluate the safety and efficacy of flow diverters (FDs) in the treatment of middle cerebral artery (MCA) aneurysms and share the follow-up (F/U) results. METHODS: The treatment and F/U results of 76 MCA aneurysms treated with the flow re-direction endoluminal device (FRE...

Descripción completa

Detalles Bibliográficos
Autores principales: Soydemir, Efe, Gündoğmuş, Cemal Aydın, Türeli, Derya, Andaç Baltacıoğlu, Nurten, Bayri, Yaşar, Baltacıoğlu, Feyyaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679704/
https://www.ncbi.nlm.nih.gov/pubmed/36988000
http://dx.doi.org/10.4274/dir.2022.211050
_version_ 1785150627248078848
author Soydemir, Efe
Gündoğmuş, Cemal Aydın
Türeli, Derya
Andaç Baltacıoğlu, Nurten
Bayri, Yaşar
Baltacıoğlu, Feyyaz
author_facet Soydemir, Efe
Gündoğmuş, Cemal Aydın
Türeli, Derya
Andaç Baltacıoğlu, Nurten
Bayri, Yaşar
Baltacıoğlu, Feyyaz
author_sort Soydemir, Efe
collection PubMed
description PURPOSE: This study aims to evaluate the safety and efficacy of flow diverters (FDs) in the treatment of middle cerebral artery (MCA) aneurysms and share the follow-up (F/U) results. METHODS: The treatment and F/U results of 76 MCA aneurysms treated with the flow re-direction endoluminal device (FRED), FRED Jr., and pipeline embolization device (PED) FD stents were evaluated retrospectively. The aneurysm occlusion rates were compared between FDs, and the integrated and jailed branches were evaluated through follow-ups. The oversizing of the stent was compared between occluded/non-occluded aneurysms and integrated branches. RESULTS: The mean F/U duration was 32 ± 6.3 months, and the mean aneurysm diameter was 4.45 mm. A total of 61 (80.3%) aneurysms were wide-necked; 73 (96.1%) were saccular; 52 (68.4%) were located at the M1 segment; and 36 (45.6%) FREDs, 23 (29.1%) FRED Jr.s, and 19 (24.1%) PEDs were used for treatment. The overall occlusion rates for the 6-, 12-, 24-, 36-, and 60-month digital subtraction angiographies were 43.8%, 63.5%, 73.3%, 85.7%, and 87.5% respectively. The last F/U occlusion rates were 67.6% for FRED, 66.7% for PED, and 60.6% for FRED Jr. (P = 0.863). An integrated branch was covered with an FD during the treatment of 63 (82.8%) aneurysms. A total of six (10%) of the integrated branches were occluded without any symptoms at the last F/U appointment. The median oversizing was 0.45 (0–1.30) for occluded aneurysms, and 0.50 (0–1.40) for non-occluded aneurysms (P = 0.323). The median oversizing was 0.70 (0.45–1.10) in occluded integrated branches and 0.50 (0–1.40) in non-occluded branches (P = 0.131). In-stent stenosis was seen in 22 (30.1%) of the stents at the 6-month F/U and in only 2 (4.7%) at the 24-month F/U. Thus, none of the patients had any neurological deficits because of the in-stent stenosis. Severe in-stent stenosis was seen in two stents. CONCLUSION: MCA aneurysms tend to be complex, with integrated branches and potentially wide necks. FD stents are safe and effective in the treatment of MCA aneurysms, and the patency of the side and jailed branches is preserved in most cases. Higher occlusion and lower in-stent stenosis rates are seen with longer F/U durations.
format Online
Article
Text
id pubmed-10679704
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-106797042023-12-05 Safety and efficacy of flow diverter stents in the treatment of middle cerebral artery aneurysms: a single-center experience and follow-up data Soydemir, Efe Gündoğmuş, Cemal Aydın Türeli, Derya Andaç Baltacıoğlu, Nurten Bayri, Yaşar Baltacıoğlu, Feyyaz Diagn Interv Radiol Interventional Radiology - Original Article PURPOSE: This study aims to evaluate the safety and efficacy of flow diverters (FDs) in the treatment of middle cerebral artery (MCA) aneurysms and share the follow-up (F/U) results. METHODS: The treatment and F/U results of 76 MCA aneurysms treated with the flow re-direction endoluminal device (FRED), FRED Jr., and pipeline embolization device (PED) FD stents were evaluated retrospectively. The aneurysm occlusion rates were compared between FDs, and the integrated and jailed branches were evaluated through follow-ups. The oversizing of the stent was compared between occluded/non-occluded aneurysms and integrated branches. RESULTS: The mean F/U duration was 32 ± 6.3 months, and the mean aneurysm diameter was 4.45 mm. A total of 61 (80.3%) aneurysms were wide-necked; 73 (96.1%) were saccular; 52 (68.4%) were located at the M1 segment; and 36 (45.6%) FREDs, 23 (29.1%) FRED Jr.s, and 19 (24.1%) PEDs were used for treatment. The overall occlusion rates for the 6-, 12-, 24-, 36-, and 60-month digital subtraction angiographies were 43.8%, 63.5%, 73.3%, 85.7%, and 87.5% respectively. The last F/U occlusion rates were 67.6% for FRED, 66.7% for PED, and 60.6% for FRED Jr. (P = 0.863). An integrated branch was covered with an FD during the treatment of 63 (82.8%) aneurysms. A total of six (10%) of the integrated branches were occluded without any symptoms at the last F/U appointment. The median oversizing was 0.45 (0–1.30) for occluded aneurysms, and 0.50 (0–1.40) for non-occluded aneurysms (P = 0.323). The median oversizing was 0.70 (0.45–1.10) in occluded integrated branches and 0.50 (0–1.40) in non-occluded branches (P = 0.131). In-stent stenosis was seen in 22 (30.1%) of the stents at the 6-month F/U and in only 2 (4.7%) at the 24-month F/U. Thus, none of the patients had any neurological deficits because of the in-stent stenosis. Severe in-stent stenosis was seen in two stents. CONCLUSION: MCA aneurysms tend to be complex, with integrated branches and potentially wide necks. FD stents are safe and effective in the treatment of MCA aneurysms, and the patency of the side and jailed branches is preserved in most cases. Higher occlusion and lower in-stent stenosis rates are seen with longer F/U durations. Galenos Publishing 2023-03-29 /pmc/articles/PMC10679704/ /pubmed/36988000 http://dx.doi.org/10.4274/dir.2022.211050 Text en © Copyright 2023 by Turkish Society of Radiology | Diagnostic and Interventional Radiology, published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc/4.0/Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Interventional Radiology - Original Article
Soydemir, Efe
Gündoğmuş, Cemal Aydın
Türeli, Derya
Andaç Baltacıoğlu, Nurten
Bayri, Yaşar
Baltacıoğlu, Feyyaz
Safety and efficacy of flow diverter stents in the treatment of middle cerebral artery aneurysms: a single-center experience and follow-up data
title Safety and efficacy of flow diverter stents in the treatment of middle cerebral artery aneurysms: a single-center experience and follow-up data
title_full Safety and efficacy of flow diverter stents in the treatment of middle cerebral artery aneurysms: a single-center experience and follow-up data
title_fullStr Safety and efficacy of flow diverter stents in the treatment of middle cerebral artery aneurysms: a single-center experience and follow-up data
title_full_unstemmed Safety and efficacy of flow diverter stents in the treatment of middle cerebral artery aneurysms: a single-center experience and follow-up data
title_short Safety and efficacy of flow diverter stents in the treatment of middle cerebral artery aneurysms: a single-center experience and follow-up data
title_sort safety and efficacy of flow diverter stents in the treatment of middle cerebral artery aneurysms: a single-center experience and follow-up data
topic Interventional Radiology - Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679704/
https://www.ncbi.nlm.nih.gov/pubmed/36988000
http://dx.doi.org/10.4274/dir.2022.211050
work_keys_str_mv AT soydemirefe safetyandefficacyofflowdiverterstentsinthetreatmentofmiddlecerebralarteryaneurysmsasinglecenterexperienceandfollowupdata
AT gundogmuscemalaydın safetyandefficacyofflowdiverterstentsinthetreatmentofmiddlecerebralarteryaneurysmsasinglecenterexperienceandfollowupdata
AT tureliderya safetyandefficacyofflowdiverterstentsinthetreatmentofmiddlecerebralarteryaneurysmsasinglecenterexperienceandfollowupdata
AT andacbaltacıoglunurten safetyandefficacyofflowdiverterstentsinthetreatmentofmiddlecerebralarteryaneurysmsasinglecenterexperienceandfollowupdata
AT bayriyasar safetyandefficacyofflowdiverterstentsinthetreatmentofmiddlecerebralarteryaneurysmsasinglecenterexperienceandfollowupdata
AT baltacıoglufeyyaz safetyandefficacyofflowdiverterstentsinthetreatmentofmiddlecerebralarteryaneurysmsasinglecenterexperienceandfollowupdata